If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Regulatory News (PXS)

Share Price Information for Provexis (PXS)

Share Price is delayed by 15 minutes
Get Live Data
1.28    -0.03 (-2.33%)
Bid:
1.23
Ask:
1.29
Spread: 0.06 (4.878%)
Market Cap: £30.03m
PXS Live PriceLast checked at - London Stock Exchange

Intraday Provexis Share Chart

Directorate Change

4 May 2007 14:35

Provexis PLC04 May 2007 4 May 2007 PROVEXIS PLC ("Provexis" or the "Company") Directorate Change Provexis plc (ticker PXS.L), the nutraceutical company that developsscientifically-proven functional and medical foods, has appointed Jonathan BrettDiggines to its Board as a non-executive director with immediate effect. Jonathan Diggines, 54, is Chief Executive Officer of Enterprise Ventures GroupLimited, a 19.4 per cent shareholder in the Company. Jonathan, who is asolicitor, joined Enterprise Ventures in 2005 and had previously spent 10 yearsas Managing Director of Murray Johnstone Private Equity where he managedsubstantial private equity and venture funds. Jonathan holds or has held thefollowing directorships or been a partner in the following partnerships withinthe five years prior to this announcement: • Enterprise Ventures (General Partner Coalfields) Limited • Enterprise Ventures (General Partner EVF/LEV) Limited • Enterprise Ventures (General Partner HSBC European Fund) Limited • Enterprise Ventures (General Partner HSBC UK Enterprise Fund) Limited • Enterprise Ventures (General Partner Rising Stars) Limited • Enterprise Ventures (General Partner Rising Stars II) Limited • Enterprise Ventures Limited • Enterprise Ventures Group Limited • Enterprise Ventures Nominees Limited • LE Founders Limited • LE Founders II Limited • LE Founders III Limited • Nichols plc • North West Enterprise Investment Limited • Rising Stars Growth Fund Limited • Carbutt & Co. (1928) Limited • LE Founders Limited • MJPAP (Syndications) Limited • MJPAP II (Syndications) Limited • T F Willow Limited • Weigh A Way Limited • W F P Willow Limited • W G Willow Limited • W I Willow Limited • W Willow Limited • British Venture Capital Association • RAL (S&G) Limited • Sumit Venture Fund One Limited • STF Management Limited • SEV Investments Limited • SEV Holdings Limited • BIG (General Partner) Limited • Regent Street Ventures Limited • Aberdeen Murray Johnstone Private Equity Limited • Euractions Management Limited • Murray Johnstone Limited • Callform Limited • Aberdeen Growth Opportunities VCT PLC • M J Founders Limited • COIP (GB) Limited • Aberdeen Asset Managers Limited • AMJPEF Founder Partner Limited • AMJPEF GP Limited There are no further disclosures to be made in accordance with Schedule 2(g) ofthe AIM Rules. Dawson Buck, Chairman of Provexis said: "I am delighted that Jonathan Diggineshas joined the Board of Provexis. He brings a considerable wealth of experiencegained from his management of venture funds and from his portfolio ofnon-executive director roles both in public and private companies, including anumber of significant food and drink sector investments. These attributescombined with his standing in the private equity and venture capital industrywill add significant value to the strategic development of our proprietarytechnologies." - ENDS - Enquiries: Provexis PlcStephen Moon, Chief Executive Officer 020 8392 6634 Arbuthnot SecuritiesTom GriffithsAlasdair Younie 020 7012 2000 Adventis Financial PRChris Steele 020 7034 4759Annie Evangeli 020 7034 4757 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Feb 20107:00 amRNSLetter of Intent for Fruitflow
28th Jan 20107:00 amRNSHolding(s) in Company
25th Jan 201010:36 amRNSHolding(s) in Company
13th Jan 20109:00 amRNSHolding(s) in Company
7th Jan 20105:06 pmRNSHolding(s) in Company
7th Jan 20104:22 pmRNSHolding(s) in Company
6th Jan 20102:53 pmRNSHolding(s) in Company
4th Jan 201011:10 amRNSTotal Voting Rights
22nd Dec 20097:00 amRNSResults of Open Offer
17th Dec 20098:15 amRNSEuropean Commission adoption of claim of Fruitflow
15th Dec 20094:40 pmRNSSecond Price Monitoring Extn
15th Dec 20094:35 pmRNSPrice Monitoring Extension
3rd Dec 20097:00 amRNSOpen Offer
3rd Dec 20097:00 amRNSHalf Yearly Report
3rd Nov 20097:00 amRNSFruitflow European Health Claim Update
27th Oct 20094:35 pmRNSPrice Monitoring Extension
20th Oct 20097:00 amRNSChange of Adviser
15th Oct 200910:46 amRNSResult of General Meeting
12th Oct 20097:00 amRNSProvexis Announces Update on Human Trial
7th Oct 20094:36 pmRNSHolding(s) in Company
2nd Oct 20091:09 pmRNSHolding(s) in Company
29th Sep 200910:00 amRNSPosting of Circular
28th Sep 20092:40 pmRNSHolding(s) in Company
25th Sep 20097:00 amRNSSubscription and Notice of General Meeting
23rd Sep 20099:54 amRNSShare Price Movement
17th Sep 20092:15 pmRNSDirectorate Change
10th Sep 20093:10 pmRNSResult of AGM
8th Sep 200912:33 pmRNSAdditional Listing
3rd Sep 20094:12 pmRNSAdditional Listing
3rd Sep 200912:37 pmRNSHolding(s) in Company
28th Aug 20098:53 amRNSRecent share price increase
26th Aug 20093:08 pmRNSDisposal of Provexis Holding
25th Aug 200910:32 amRNSHolding(s) in Company
25th Aug 200910:27 amRNSHolding(s) in Company
17th Aug 20099:25 amRNSAnnual Financial Report
11th Aug 20094:22 pmRNSHolding(s) in Company
11th Aug 20097:00 amRNSCommencement of Clinical Trial
10th Aug 20099:43 amRNSRecent share price movement
2nd Jul 20094:44 pmRNSHolding(s) in Company
9th Jun 20097:00 amRNSAudited Results Year ended 31 March 2009
28th May 20097:00 amRNSEuropean Health Claim Adoption for Fruitflow
4th Feb 20097:00 amRNSSirco Launch
3rd Feb 200912:39 pmRNSR&D Pipeline Update
3rd Feb 200911:32 amRNSFurther re Agreement
2nd Dec 20087:00 amRNSInterim Results
3rd Oct 200810:47 amRNSHolding(s) in Company
2nd Oct 20083:17 pmRNSDirector/PDMR Shareholding
2nd Oct 200811:08 amRNSResult of AGM
1st Oct 20087:00 amRNSDirectorate Change
16th Sep 20083:22 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.